The Food and Drug Administration today announced a voluntary pilot program to expedite approvals of certain changes to ethylene oxide sterilization processes and facilities. Under the pilot program, facilities that use fixed-chamber ethylene oxide sterilization processes to sterilize single-use medical devices would submit a “master file” to the FDA when making certain changes to their location or changes to their sterilization processes that use lower ethylene oxide concentrations. The FDA believes the program will allow more efficient review and feedback, ultimately allowing the agency to provide a more nimble response to site closures in the future. In addition, FDA said it will work with 12 applicants to its innovation challenges to accelerate the development and review of innovative technologies for sterilization processes, and is moving forward with certain recommendations from its recent advisory committee meeting.

Related News Articles

Chairperson's File
Smarter, more efficient, more convenient. These goals are shaping transformation at hospitals and health systems throughout the country.
Headline
The Food and Drug Administration Friday approved the first duodenoscope with a disposable elevator component, a part difficult to clean and reprocess.
Headline
The AHA and Concord Health Partners today announced the launch of a $50 million venture capital fund to invest in early-stage health care companies.
Headline
The Food and Drug Administration should study potential alternatives to ethylene oxide for sterilizing medical devices, but a solution could be at least a…
#HealthCareInnovation Thursday Blog
In this blog, Andy Shin, chief operating officer of the AHA Center for Health Innovation, discusses an ecosystem approach to health care transformation.
#HealthCareInnovation Thursday Blog
Maryjane Wurth, AHA executive vice president and COO, previews a new blog series focused on innovation and transformation.